Research & Facility Resources

Items for Action

  1. Researchers approved to come to campus must track their symptoms each day with the Protect Texas Together app before reporting to work.

  2. Phase 3 of Research Restart is in place now. PIs interested in restarting research on campus should visit the College Research Restart page and follow the steps outlined there. 

  3. Follow all cohort scheduling regulations, beginning on July 27. All researchers in the same building or complex must follow the same cohort schedule, even researchers who do not wish to bring back additional members of their group and instead choose to maintain your lab as a single cohort at 33% workforce. Find the cohort schedules adopted by each CNS building and descriptions of each model. 

  4. Researchers also should review the latest requirements for research operations, research travel and restarting at the VPR's COVID-19 FAQ page.

General Resources

Facilities and Supplies

  • There is an NHB receiving area (1.512) open for package receipt and as a pick-up location for UPS / Fed Ex / DHL. Packages need to be fully prepared prior to drop-off. The area is open until 3 pm M-F.
  • Building access requires use of UT ID at the celebrated entrance to each building. More about that is at the Financial and Administrative Services dedicated web page.
  • The Center for Biomedical Research Support (CBRS), a core facility, is posting updates here. For questions or requests, contact Andreas Matouschek.
  • The STEM stockroom remains open 9am-1pm Monday – Friday in NHB 1.502.  Contact Gilbert Pinto (gilbert.pinto@austin.utexas.edu) with questions or call 512-471-7462 for access.
  • Liquid nitrogen is available through the Biomedical Research Supplies Core in MBB 1.316. Contact Michelle at 512-471-2895 (icmbsc@austin.utexas.edu) with questions.

Travel

  • Restrictions on student, faculty and staff domestic aninternational travel are in place through at least December 31. (On October 15, university leadership will review extending that deadline again.)

COVID-19 Research